Evidence mapPaperPMID 41753669Full record

ArticleMicroorganisms2026

Genomic Characterization, Safety Assessment, and Probiotic Potential of a Novel Human-Derived

Dongxiong Hu, Jiao Yan, Yuxin Li, Jun Wu, Yifan Xie, Lirong Peng, Erhong Zhang, Hao Jiang, Qinmiao Sun, Xiao Chu

Abstract read
In one paragraph

Article in Microorganisms, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Dongxiong HuInstitute of Biomedical Research, Yunnan University, Kunming 650500, China.
Jiao YanInstitute of Biomedical Research, Yunnan University, Kunming 650500, China.
Yuxin LiInstitute of Biomedical Research, Yunnan University, Kunming 650500, China.ORCID 0009-0003-9980-6548
Jun WuInstitute of Biomedical Research, Yunnan University, Kunming 650500, China.
Yifan XieInstitute of Biomedical Research, Yunnan University, Kunming 650500, China.
Lirong PengInstitute of Biomedical Research, Yunnan University, Kunming 650500, China.
Erhong ZhangInstitute of Biomedical Research, Yunnan University, Kunming 650500, China.
Hao JiangInstitute of Biomedical Research, Yunnan University, Kunming 650500, China.
Qinmiao SunState Key Laboratory of Organ Regeneration and Reconstruction, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.ORCID 0000-0001-8091-1653
Xiao ChuInstitute of Biomedical Research, Yunnan University, Kunming 650500, China.

Funding

China Postdoctoral Science Foundation 2025M772579Natural Science Foundation of Yunnan Province 202401AU070227
6 · The paper itself

Abstract

Probiotic strains exhibiting bile salt hydrolase (BSH) activity represent a promising therapeutic strategy for ameliorating metabolic disorders via targeting the gut-liver axis. Herein, we characterized a newly isolated human-derived

Indexed as

bile salt hydrolaseEnterococcus lactishuman gut bacteriaprobioticssafety assessment

Identifiers

PMID41753669
PMCPMC12943309

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.